A new over-the-counter COVID-19 test has been authorized by the FDA. Though it can be used to test people with and without symptoms, moderate cost and limited production mean it isn’t a game-changer.
Academic rigour, journalistic flair
Articles on Food and Drug Administration (FDA)
Displaying 81 - 100 of 161 articles
Millions of Americans say they won’t get the vaccine. Will money change their minds? And is luring them with cash the right approach?
The vaccines that will first be used to prevent the spread of COVID-19 will have gone through a special approval process with the FDA. but just what is this expedited process?
Australia is still aiming to start vaccinating high-risk groups from March. Why the delay?
The jury’s still out on whether or not CBD relieves stress and anxiety.
Many people object to the added ingredients in vaccines. But pharmacists explain why those fears are unwarranted.
Popular pain medicines sold over the counter could be bad for a developing fetus. A pharmacologist explains why, and why the FDA is warning pregnant women to avoid these drugs.
Several vaccines are in Phase 3 trials. So when will we know whether any of these will protect against COVID-19?
There are ingredients in your pills other than the one designed to treat your ailments. Those unnamed ingredients can alter how you respond to a medicine or even make you sick.
The new BinaxNOW antigen test is quick, easy, accurate and cheap. It could solve the US testing problem, but the emergency use authorization only allows people with COVID-19 symptoms to get tested.
The rushed emergency approval for a treatment that might help COVID-19 patients has raised questions: Is the FDA abandoning its own guidelines?
Aerosols of some FDA-approved food coloring could deactivate airborne viruses.
Consuming the plant can be lethal to animals and humans.
Testing large numbers of people regularly would reduce the spread of the coronavirus in the US. Laboratory testing is slow and expensive, but rapid screening tests could be the answer.
After firms add more women to their board, dangerous medical products are recalled more quickly.
The FDA has sped up its approval process for coronavirus treatments, creating a new division to expedite the regulatory process. But is safety being sidelined for speed?
Researchers are developing a seasonal shot that blocks Lyme disease-causing bacteria from a tick.
Drugs and vaccines to fight the coronavirus are already in clinical trials. It is important to understand the difference between each step in this process as efforts to fight COVID-19 continue.
Vaccine development is usually a long process. The coronavirus pandemic is forcing researchers to innovate and test potential vaccines faster than ever before.
Researchers at the University of California, San Francisco, identified nine existing drugs that show promise to treat COVID-19. The proteins they target haven’t been tried before.
Top contributors
-
Distinguished Professor of Pharmacy Practice, University of Connecticut
-
Professor of Law, Villanova School of Law
-
Associate Professor of Public Policy, University of Maryland, Baltimore County
-
Associate Professor of Pharmacy and Therapeutics, University of Pittsburgh
-
Joel Lexchin is a Friend of The Conversation.
Professor Emeritus of Health Policy and Management, York University, Canada
-
Associate Professor of Molecular Medicine, UMass Chan Medical School
-
Professor and Dean, School of Public Health, Georgia State University
-
Instructor of Human Immunology, Emory University
-
Associate Professor of Pediatrics, University of Virginia
-
Clinical Associate Professor of Pharmacy Practice, Binghamton University, State University of New York
-
Associate Professor of Operations and Decision Technologies, Kelley School of Business, Indiana University
-
Professor of Law, George Washington University
-
Doctorate in Health Sciences candidate, George Washington University
-
Professor and Director of Quantitative Biosciences Institute & Senior Investigator at the Gladstone Institutes, University of California, San Francisco
-
Associate Professor of Legal Studies and Political Science, UMass Amherst
